# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community-Based Organizations, Funding Opportunity Announcement (FOA), PS10-1003, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
*Times and Dates:*
8:30 a.m.-5:30 p.m., December 6, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 7, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 8, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 9, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 10, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 11, 2009 (Closed)
8:30 a.m.-5:30 p.m., December 12, 2009 (Closed)
*Place:* Sheraton Atlanta Hotel, 165 Courtland Street, NE., Atlanta, Georgia, 30303, Telephone (404) 659-6500.
*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters To Be Discussed:* The meeting will include the initial review, discussion, and evaluation of “HIV Prevention Projects for Community-Based Organizations, FOA PS10-003.”
*Contact Person For More Information:* Monica Farmer, M.Ed., Public Health Analyst, Strategic Science and Program Unit, Office of the Director, Coordinating Center for Infectious Diseases, CDC, 1600 Clifton Road, NE., Mailstop E-60, Atlanta, GA 30333, *Telephone:* (404) 498-2277.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: August 5, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.